Premium
Venetoclax and arsenic showed synergistic anti‐leukemia activity in vitro and in vivo for acute myeloid leukemia with the NPM1 mutation
Author(s) -
Zhu HongHu,
Qian JieJing,
Sun WanJun,
You LiangShun,
Wang Qian Qian,
Naranmandura Hua,
Jin Jie
Publication year - 2020
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25719
Subject(s) - npm1 , myeloid leukemia , venetoclax , in vivo , leukemia , cancer research , in vitro , mutation , medicine , pharmacology , biology , immunology , gene , genetics , chronic lymphocytic leukemia , karyotype , chromosome